Clinical Trial Update: Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib for reversing chemotherapy resistance in advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Malignant Neoplasm of Stomach Stage II | Phase 2 | Status: UNKNOWN